Design of a liposomal formulation aimed to vaccines administration
Abstract
Antigen is not the single component involved in the pharmacological response for vaccines but additional factors such as formulation and adjuvant compounds play a relevant role. Several strategies based on the use of liposomes are currently assayed in this field. According to this, the aim of the present work was the design, preparation and characterization of a pharmaceutical vehicle able to produce a rapid delivery of adjuvants and a slow release of antigen. From the know-how a theoretical vehicle was design and proposed as optimal formulation and this was then prepared and characterized. The “proposed formulation” is based on albumin coated liposomes made of egg phosphatidylcholine, cholesterol and diethyldodeccyiamonium. The applied procedure carried out in absence of organic solvents allowed for obtaining liposomes with a 20-70 nm aerodynamic diameter range and a zeta potential mean value of 61.9 ±2.08 mV and also for its coating with albumin. Coated particles showed a spherical shape and a size range of 2-10 µm which does not fulfil parenteral formulations requirements but are optimal for nasal or dermatological administration routes.
- Referencias
- Cómo citar
- Del mismo autor
- Métricas
Similar Articles
- Juan José Duque Aguilar, María José Jesús Del Valle, Amparo Sánchez Navarro, Microencapsulation of ciprofloxacin in microspheres of albumin and liposomes (Albusomes) , FarmaJournal: Vol. 2 No. 2 (2017)
- María José Sanchez-Carpintero, Amparo Sanchez-Navarro, María José De Jesus-valle, Liposomes isolation and characterization by microencapsulation , FarmaJournal: Vol. 1 No. 1 (2016)
- Sara Viruega-Encinas, María José De Jesús-valle, Microencapsulation of antifungal agents in albumin coated liposomes , FarmaJournal: Vol. 2 No. 2 (2017)
- Diego Gallego, Clara Isabel Colino, Formulation and Optimization of Lipid Nanoparticles with Chitosan for Quercetin Delivery , FarmaJournal: Vol. 8 No. 2 (2023)
- Darío Perallón Mantas, Javier Sánchez Montejo, Antonio Muro Álvarez, Advances in the Development of New Vaccines against Fasciola hepatica , FarmaJournal: Vol. 8 No. 1 (2023)
- Azahara I. Toro, María José de Jesús Valle, Drug delivery from liposomes in different biorelevant media , FarmaJournal: Vol. 6 No. 1 (2021)
- Laura Garrido de Gracia, María José de Jesús Valle, Aránzazu Zarzuelo Castañeda, Amparo Sánchez Navarro, Development of Mucoadhesive Oral Formulations Based on Resveratrol Liposomes , FarmaJournal: Vol. 10 No. 2 (2025)
- Jimena Barbero, Amparo Sánchez Navarro, María José de Jesús-Valle, Ergosterol Liposomes in Lyophilized Formulations for Buccal Administration , FarmaJournal: Vol. 9 No. 2 (2024)
- Blanca Calderón García, María José De Jesús Valle, Lyophillization of Liposomes for Pulmonary Administration , FarmaJournal: Vol. 7 No. 2 (2022)
- Ángela Pérez Sancho, Ramona Mateos Campos, Evaluation of Knowledge, Attitudes and Behaviours about Vaccines in the Population , FarmaJournal: Vol. 8 No. 1 (2023)
You may also start an advanced similarity search for this article.